Co-occurrence of mutations modifying RAS and EZH2 inactivation in chronic myelomonocytic leukemia causes amplification of RAS-AKT signaling and increases the sensitivity to AKT inhibitors
- Telebar-Zbulj, F. (Speaker)
- JL Berg (Author)
- Perfler, B. (Author)
- Bramreiter, B. L. (Author)
- Veronica Caraffini (Author)
- Prokesch, A. (Author)
- K Geissler (Author)
- T Penz (Author)
- Manuel Schuster (Author)
- Reinisch, A. (Author)
- Wölfler, A. (Author)
- Sill, H. (Author)
- Zebisch, A. (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › On site